Merck held talks to buy biotech MoonLake for over $3 billion, FT reports

(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported on Monday, citing three people familiar with the matter.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shounak Dasgupta)